Permanent Activation of the Human P-glycoprotein by Covalent Modification of a Residue in the Drug-binding Site
Open Access
- 1 June 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (23) , 20449-20452
- https://doi.org/10.1074/jbc.c300154200
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Mammalian ABC Transporters in Health and DiseaseAnnual Review of Biochemistry, 2002
- Molecular genetic analysis and biochemical characterization of mammalian P-glycoproteins involved in multidrug resistanceSeminars in Cell & Developmental Biology, 2001
- Multidrug resistance (MDR) in cancerEuropean Journal of Pharmaceutical Sciences, 2000
- The Transmembrane Domains of the Human Multidrug Resistance P-glycoprotein Are Sufficient to Mediate Drug Binding and Trafficking to the Cell SurfacePublished by Elsevier ,1999
- HIV-1 Protease Inhibitors Are Substrates for theMDR1 Multidrug TransporterBiochemistry, 1998
- The Minimum Functional Unit of Human P-glycoprotein Appears to be a MonomerPublished by Elsevier ,1996
- Transmembrane Organization of Mouse P-glycoprotein Determined by Epitope Insertion and ImmunofluorescencePublished by Elsevier ,1996
- Covalent Modification of Human P-glycoprotein Mutants Containing a Single Cysteine in Either Nucleotide-binding Fold Abolishes Drug-stimulated ATPase ActivityPublished by Elsevier ,1995
- Membrane Topology of a Cysteine-less Mutant of Human P-glycoproteinJournal of Biological Chemistry, 1995
- Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cellsCell, 1986